Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Transaction in Own Shares

29 Oct 2024 07:00

RNS Number : 9020J
Indivior PLC
29 October 2024
 

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

October 29, 2024

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total of 324,159 of its ordinary shares of $0.50 each through Morgan Stanley & Co. International Plc in the period from October 21, 2024, up to and including October 25, 2024, in connection with its $100m Share Repurchase Program. Aggregated information on the purchase of these shares can be found in the table below.

Following the purchase and cancellation of the above shares (including those purchased but not yet settled), Indivior has 127,883,551 ordinary shares of $0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (127,883,551) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Indivior under the FCA's Disclosure Guidance and Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is defined in the rules of the London Stock Exchange) and "on market" for the purposes of the Companies Act 2006.

Aggregated information

Trading Date

Trading Venue

Aggregated daily volume (number of shares)

Daily weighted average purchase price of the shares (p)

21/10/2024

LSE

14,350

645.70

22/10/2024

LSE

57,681

651.74

22/10/2024

BATE

14,522

650.07

22/10/2024

CHIX

48,049

651.27

22/10/2024

AQUIS

2,942

649.98

23/10/2024

LSE

125,445

670.08

23/10/2024

BATE

1,062

673.00

23/10/2024

CHIX

1,219

672.81

23/10/2024

AQUIS

129

673.00

24/10/2024

LSE

11,143

686.45

25/10/2024

LSE

31,923

692.94

25/10/2024

BATE

4,707

692.71

25/10/2024

CHIX

10,085

693.01

25/10/2024

AQUIS

902

693.22

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation (EU) No 596/2014, as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU) 2016/1052, a full breakdown of the individual purchases of ordinary shares made by Morgan Stanley & Co. International Plc on behalf of Indivior during the above period as part of the Share Repurchase Program can be found at www.indivior.com/en/investors/shareholder-information/share-repurchase-program.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZMZGZRMGDZM
Date   Source Headline
25th Jul 20257:00 amRNSIndivior Announces Completion of London Delisting
24th Jul 20253:52 pmRNSHolding(s) in Company
24th Jul 20258:34 amRNSHolding(s) in Company
23rd Jul 20258:08 amRNSHolding(s) in Company
21st Jul 20254:23 pmRNSHolding(s) in Company
21st Jul 20258:33 amRNSHolding(s) in Company
18th Jul 20258:35 amRNSHolding(s) in Company
17th Jul 20252:00 pmRNSNotice of Results
1st Jul 20258:46 amRNSHolding(s) in Company
1st Jul 20258:43 amRNSHolding(s) in Company
1st Jul 20258:37 amRNSHolding(s) in Company
1st Jul 20258:34 amRNSHolding(s) in Company
1st Jul 20257:49 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSIndivior Announces Inclusion in US Russell Indexes
25th Jun 20257:00 amRNSIndivior Appoints Tony Kingsley to the Board
17th Jun 20254:42 pmRNSHolding(s) in Company
13th Jun 20258:10 amRNSDirector/PDMR Shareholding - Correction
12th Jun 20254:24 pmRNSDirector/PDMR Shareholding
10th Jun 20254:12 pmRNSHolding(s) in Company
6th Jun 20254:49 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSIndivior Announces Intent to Cancel LSE Listing
15th May 20253:30 pmRNSDirector/PDMR Shareholding
13th May 20253:00 pmRNSIndivior to Participate in Upcoming Events
9th May 20254:37 pmRNSAmendment to Result of AGM
8th May 20252:31 pmRNSBlock listing Interim Review
8th May 20252:00 pmRNSResult of AGM
6th May 20251:48 pmRNSDirector/PDMR Shareholding
1st May 20259:21 amRNSTotal Voting Rights
24th Apr 20257:00 amRNS1st Quarter Results
22nd Apr 20251:58 pmRNSHolding(s) in Company
10th Apr 20254:51 pmRNSNotice of Results
3rd Apr 202512:31 pmRNSHolding(s) in Company
1st Apr 202511:19 amRNSTotal Voting Rights
28th Mar 20258:33 amRNSHolding(s) in Company
27th Mar 20252:00 pmRNSNotice of AGM
21st Mar 20253:40 pmRNSHolding(s) in Company
17th Mar 20251:25 pmRNSDirector/PDMR Shareholding
17th Mar 20251:17 pmRNSAnnual Financial Report
14th Mar 20253:44 pmRNSDirector/PDMR Shareholding
14th Mar 202510:03 amRNSHolding(s) in Company
11th Mar 202512:41 pmRNSDirector/PDMR Shareholding
11th Mar 202510:18 amRNSDirector/PDMR Shareholding
10th Mar 20255:39 pmRNSDirector/PDMR Shareholding
5th Mar 20252:02 pmRNSDirector/PDMR Shareholding
4th Mar 20251:45 pmRNSHolding(s) in Company
4th Mar 202511:23 amRNSDirector/PDMR Shareholding
4th Mar 202511:23 amRNSHolding(s) in Company
4th Mar 20257:00 amRNSFurther Changes to Board of Directors
4th Mar 20257:00 amRNSIndivior PLC Files 2024 Annual Report on Form 10-K
3rd Mar 20259:29 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.